BRPI0605907A2 - processo aperfeiçoado para a preparação de letrozol - Google Patents

processo aperfeiçoado para a preparação de letrozol

Info

Publication number
BRPI0605907A2
BRPI0605907A2 BRPI0605907-4A BRPI0605907A BRPI0605907A2 BR PI0605907 A2 BRPI0605907 A2 BR PI0605907A2 BR PI0605907 A BRPI0605907 A BR PI0605907A BR PI0605907 A2 BRPI0605907 A2 BR PI0605907A2
Authority
BR
Brazil
Prior art keywords
preparation
benzonitrile
letrozole
improved process
triazolyl
Prior art date
Application number
BRPI0605907-4A
Other languages
English (en)
Inventor
Peter Lindsey Macdonald
Ettore Bigatti
Pierluigi Rossetto
Ziv Harel
Original Assignee
Sicor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sicor Inc filed Critical Sicor Inc
Publication of BRPI0605907A2 publication Critical patent/BRPI0605907A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCESSO APERFEIçOADO PARA A PREPARAçãO DE LETROZOL. A invenção fornece um processo de rendimento elevado para a preparação de letrozol com pureza elevada, sem a necessidade de remoção de impreza de 4-[1-(1,3,4-triazolil)metil] benzonitrila no estágio intermediário. A invenção também fornece um processo para síntese de letrezol em que a formação da impureza 4-[1-(1,3,4-triazolil)metil] benzonitrila durante o primeiro estágio é minimizada. no processo, 4-(halometil)benzonitrila reage com um sal de 1H-1,2,4-triazol, reduzindo a formação da impureza. Preferencialmente, a preparação é realizada como um processo de uma única etapa.
BRPI0605907-4A 2005-07-06 2006-07-06 processo aperfeiçoado para a preparação de letrozol BRPI0605907A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69721705P 2005-07-06 2005-07-06
PCT/US2006/026980 WO2007100346A1 (en) 2005-07-06 2006-07-06 Improved process for the preparation of letrozole

Publications (1)

Publication Number Publication Date
BRPI0605907A2 true BRPI0605907A2 (pt) 2009-05-26

Family

ID=37431706

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0605907-4A BRPI0605907A2 (pt) 2005-07-06 2006-07-06 processo aperfeiçoado para a preparação de letrozol

Country Status (8)

Country Link
US (1) US7705159B2 (pt)
EP (1) EP1871750A1 (pt)
JP (1) JP2008516005A (pt)
KR (1) KR100917698B1 (pt)
CN (1) CN101253160A (pt)
BR (1) BRPI0605907A2 (pt)
CA (1) CA2608904A1 (pt)
WO (1) WO2007100346A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2608904A1 (en) 2005-07-06 2007-09-07 Sicor Inc. Improved process for the preparation of letrozole
US7465749B2 (en) * 2005-11-14 2008-12-16 Chemagis, Ltd. Letrozole purification process
GB2450268B (en) * 2006-03-17 2011-01-12 Cipla Ltd Synthesis of 4-[1-(4-cyano phenyl)-1-(1,2,4-triazol-1-yl)methyl]benzonitrile and 4-[1-(1,2,4-triazol-1-yl)methyl]benzonitrile intermediate
US8063083B2 (en) * 2006-05-25 2011-11-22 Synta Pharmaceuticals Corp. Method for treating non-Hodgkin's lymphoma
WO2009069140A1 (en) * 2007-11-28 2009-06-04 Dabur Pharma Limited An improved process for preparation of letrozole and its intermediates
WO2011000396A1 (en) * 2009-07-02 2011-01-06 Synthon B.V. Purification of letrozole intermediate
EP2560640A1 (en) 2010-04-19 2013-02-27 Synta Pharmaceuticals Corp. Cancer therapy using a combination of a hsp90 inhibitory compounds and a egfr inhibitor
NZ607428A (en) 2010-08-27 2015-10-30 Generics Uk Ltd Pure intermediate for preparing letrozole
JP2014534228A (ja) 2011-11-02 2014-12-18 シンタ ファーマシューティカルズ コーポレーション 白金含有剤とｈｓｐ９０阻害剤の組合せ療法
CA2853799A1 (en) 2011-11-02 2013-05-10 Synta Pharmaceuticals Corp. Cancer therapy using a combination of hsp90 inhibitors with topoisomerase i inhibitors
US9402831B2 (en) 2011-11-14 2016-08-02 Synta Pharmaceutical Corp. Combination therapy of HSP90 inhibitors with BRAF inhibitors
CN103242198A (zh) * 2013-04-25 2013-08-14 哈药集团制药总厂 一种来曲唑杂质的制备方法
CN103664810B (zh) * 2013-12-11 2016-09-14 深圳劲创生物技术有限公司 一种合成来曲唑的工艺
IL304863B2 (en) 2017-09-11 2025-08-01 Atossa Therapeutics Inc Methods for making and using endoxifen
CN109721558B (zh) * 2017-10-27 2025-11-18 中国医学科学院药物研究所 来曲唑晶iii型固体物质及制备方法和其药物组合物与用途
CN109721557B (zh) * 2017-10-27 2025-11-18 中国医学科学院药物研究所 来曲唑晶ii型固体物质及制备方法和其药物组合物与用途
JP7662204B2 (ja) 2019-07-03 2025-04-15 アトッサ・セラピューティクス・インコーポレイテッド エンドキシフェンの徐放性組成物
CN117924195A (zh) * 2023-08-23 2024-04-26 中科帆凯(大连)新材料有限公司 一种制备纯的来曲唑中间体的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978672A (en) * 1986-03-07 1990-12-18 Ciba-Geigy Corporation Alpha-heterocyclc substituted tolunitriles
US4749713A (en) * 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US5352795A (en) * 1986-03-07 1994-10-04 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
DE3926365A1 (de) * 1989-08-04 1991-02-07 Schering Ag Cycloalkylenazole, verfahren zu deren herstellung, pharmazeutische praeparate, die diese enthalten sowie ihre verwendung zur herstellung von arzneimitteln
WO2004076409A2 (en) * 2003-02-06 2004-09-10 Sun Pharmaceutical Industries Limited Regiospecific process for the preparation of 4-[1- (4-cyanophenyl)-1-(1,2,4-triazol-1-yl)methyl]benzonitrile
AU2003282380A1 (en) 2003-11-14 2004-06-06 ADIBHATLA, KALI,SATYA, Bhujanga,rao A method for the separation of the letrozole precursor 4-1-(1,2,4-triazolyl) methyl benzonitrile from its 1,3,4-triazolyl isomer
US20050209294A1 (en) * 2004-03-17 2005-09-22 Wadhwa Lalit K Process for producing 4-(1H-1,2,4-triazol-1-ylmethyl)benzonitrile
CA2608904A1 (en) 2005-07-06 2007-09-07 Sicor Inc. Improved process for the preparation of letrozole
WO2007039912A1 (en) 2005-10-05 2007-04-12 Usv Limited A one pot process for the preparation of 4-[1-cyanophenyl)-1-(1,2,4-triazol-1-yl)methyl]benzonitrile
WO2007054964A2 (en) 2005-10-20 2007-05-18 Cadila Healthcare Limited Process for the preparation of letrozole
US20070100149A1 (en) * 2005-11-02 2007-05-03 Palle Venkata Raghavendra A Process for preparing letrozole
US7465749B2 (en) * 2005-11-14 2008-12-16 Chemagis, Ltd. Letrozole purification process
US7538230B2 (en) * 2005-11-14 2009-05-26 Chemagis Ltd. Letrozole production process
WO2007074474A1 (en) 2005-12-27 2007-07-05 Dabur Pharma Limited Novel intermediates for preparation of letrozole
WO2007090464A1 (en) 2006-02-08 2007-08-16 Solmag S.P.A. Process for preparing letrozole
GB2450268B (en) 2006-03-17 2011-01-12 Cipla Ltd Synthesis of 4-[1-(4-cyano phenyl)-1-(1,2,4-triazol-1-yl)methyl]benzonitrile and 4-[1-(1,2,4-triazol-1-yl)methyl]benzonitrile intermediate
WO2007128561A1 (en) * 2006-05-04 2007-11-15 Synthon B.V. Crystalline forms of letrozole and processes for making them
WO2007144896A1 (en) 2006-06-13 2007-12-21 Natco Pharma Limited A method of manufacture of letrozole
WO2008090565A1 (en) 2007-01-22 2008-07-31 Natco Pharma Limited Novel thermodynamically stable polymorphic form-l of letrozole

Also Published As

Publication number Publication date
US20070066831A1 (en) 2007-03-22
US7705159B2 (en) 2010-04-27
CN101253160A (zh) 2008-08-27
WO2007100346A1 (en) 2007-09-07
JP2008516005A (ja) 2008-05-15
KR20070105299A (ko) 2007-10-30
CA2608904A1 (en) 2007-09-07
KR100917698B1 (ko) 2009-09-21
EP1871750A1 (en) 2008-01-02

Similar Documents

Publication Publication Date Title
BRPI0605907A2 (pt) processo aperfeiçoado para a preparação de letrozol
NZ594181A (en) Fungicidal pyrazoles
IL176547A0 (en) 1,3,5-trisubstituted 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
PE20091618A1 (es) 1,2,4-triazoles trisustituidos
IL281196A (en) Process for the preparation of methyl 6-(4,2-dichlorophenyl)-5-[4-[(S3)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-9,8-dihydro-H7-benzo[ 7]Anolene-2-carboxylate
WO2004048345A3 (en) 2,5-diketopiperazines for the treatment of obesity
NZ612119A (en) Use of sigma ligands in bone cancer pain
CA2727528A1 (en) Heme-oxygenase inhibitors and use of the same in the treatment of cancer and diseases of the central nervous system
CL2014000384A1 (es) Compuestos fungicidas de 1-(2-(2-halo-4-(4-halogen-fenoxi)-fenil)-2-alcoxi-2-alquinil/alquenil-etil)-1h-(1,2,4) triazol sustituidos; proceso para preparar dichos compuestos; composiciones agroquímicas.
ATE510453T1 (de) Synergistische fungizide wirkstoffkombinationen enthaltend spiroxamine, prothioconazole und bixafen
IL186809A0 (en) Solid forms of 1-(5-(ih-i,2,4-triazol-5-yl)(1h-indazol-3-yl))-3-(2-piperidylethoxy)benzene
WO2010145999A3 (de) Fungizide mischungen
WO2011110583A3 (en) Fungicidal mixtures comprising triazole derivatives
RU96110883A (ru) Тетрагидропиридин-(или 4-гидроксипиперидин)-алкилазолы, обладающие активностью по отношению к рецепторам сигма- и/или 5нт1а-типа
AU600107B2 (en) 4-(4-(4-((2-(2,4-difluorophenyl)-2-(1h-azolylmethyl)-1,3- dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)phenyl) triazolones
ATE455103T1 (de) Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
ES2223893T3 (es) Combinaciones de productos activos fungicidas.
WO2004076409A3 (en) Regiospecific process for the preparation of 4-[1- (4-cyanophenyl)-1-(1,2,4-triazol-1-yl)methyl]benzonitrile
GB2450268A (en) Synthesis of 4-[1-(4-Cyano Phenyl)-(1,2,4-Triazol-1-YL)Methyl] Benzonitrile and 4-[1-(1-H-1,2,4-Triazol-1-YL)Methylene Benzonitrile Intermediate
CO2018011948A2 (es) Procedimiento para la preparación de derivados de 1-fenilo-1,2,4- triazol sustituidos por 5-hidroxialquilo
DOP2014000254A (es) Metodo para la preparacion de compuestos de triazol
NO20065327L (no) Fremgangsmate for fremstilling av derivarer av 5-'4-(2-hydroksy-propyl)-3,5-dihydro-3H'1, 2,4(triazin-2-yl)-benzamid.
IL139649A (en) Water-soluble azulis, broad-spectrum antifungals, their preparation process and pharmaceutical preparations containing them
WO2003082256A3 (fr) Traitement des dysfonctionnements sexuels a l'aide d'un antagoniste des recepteurs aux cannabinoides cb1
WO2007013096A8 (en) Improved process for the preparation of 2r, 3s-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl) butan-2-ol (voriconazole)

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 3A, 4A, 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012.